PPA
TTPH

Parametric Portfolio Associates’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Parametric Portfolio Associates’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,041
Closed -$55K – 4028
2019
Q1 		$55K Sell
2,041
-6,235
-75% -$159K ﹤0.01% 3885
2018
Q4 		$187K Buy
8,276
+1,744
+27% +$68.2K ﹤0.01% 3675
2018
Q3 		$361K Sell
6,532
-541
-8% -$34.5K ﹤0.01% 3561
2018
Q2 		$505K Buy
7,073
+1,283
+22% +$90.6K ﹤0.01% 3345
2018
Q1 		$355K Buy
5,790
+1,553
+37% +$136K ﹤0.01% 3505
2017
Q4 		$534K Buy
4,237
+856
+25% +$110K ﹤0.01% 3298
2017
Q3 		$463K Sell
3,381
-99
-3% -$13.2K ﹤0.01% 3465
2017
Q2 		$496K Buy
3,480
+359
+12% +$55.5K ﹤0.01% 3380
2017
Q1 		$574K Buy
3,121
+573
+22% +$64.2K ﹤0.01% 3136
2016
Q4 		$205K Buy
2,548
+115
+5% +$9.1K ﹤0.01% 3584
2016
Q3 		$186K Buy
2,433
+941
+63% +$75.4K ﹤0.01% 3588
2016
Q2 		$128K Buy
+1,492
New +$137K ﹤0.01% 3698
2015
Q4 		– Sell
-535
Closed -$80K – 4005
2015
Q3 		$80K Sell
535
-400
-43% -$294K ﹤0.01% 3213
2015
Q2 		$887K Buy
935
+195
+26% +$159K ﹤0.01% 2888
2015
Q1 		$542K Buy
740
+21
+3% +$15.8K ﹤0.01% 3220
2014
Q4 		$571K Buy
+719
New +$387K ﹤0.01% 3199

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Parametric Portfolio Associates's TTPH Position: Q2 2019 in Review

Parametric Portfolio Associates sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 2,041 shares — an estimated $55K sold.

Parametric Portfolio Associates first reported a position in TTPH in Q4 2014 and held it in 16 quarters. The position peaked at $887K in Q2 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • Parametric Portfolio Associates reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 2,041 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $55K.
  • Parametric Portfolio Associates first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 16 quarters.
  • Parametric Portfolio Associates's Tetraphase Pharmaceuticals, Inc. position peaked at $887K in Q2 2015.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on Parametric Portfolio Associates's 13F filing for Q2 2019, filed 13 Aug 2019.